Personalized Ophthalmology Therapies Global Market Report 2025

Description

Personalized ophthalmology therapies are customized treatment approaches for eye diseases and vision disorders that are tailored to an individual patient's genetic profile, molecular characteristics, lifestyle, and clinical condition. These therapies utilize advances in genomics, biomarker analysis, imaging, and precision medicine to optimize drug selection, dosage, or surgical interventions for conditions such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and inherited retinal diseases.

The primary types of personalized ophthalmology therapies include gene therapy, cell therapy, pharmacogenomics, targeted drug delivery, and others. Gene therapy involves introducing or modifying genetic material within a patient's cells to treat eye diseases caused by genetic mutations. These therapies are applied for various indications including AMD, diabetic retinopathy, glaucoma, and retinitis pigmentosa, and are used by hospitals, specialty clinics, research institutes, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The personalized ophthalmology therapies market research report is one of a series of new reports from The Business Research Company that provides personalized ophthalmology therapies market statistics, including personalized ophthalmology therapies industry global market size, regional shares, competitors with a personalized ophthalmology therapies market share, detailed personalized ophthalmology therapies market segments, market trends and opportunities, and any further data you may need to thrive in the personalized ophthalmology therapies industry. This personalized ophthalmology therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized ophthalmology therapies market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. Growth in the historic period was driven by rising rates of diabetes, government initiatives, an aging population, growing demand for precision medicine in eye care, and increasing prevalence of ophthalmic diseases.

The personalized ophthalmology therapies market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. Growth in the forecast period is expected to be supported by greater accessibility of genetic testing and molecular diagnostics, increasing cases of age-related macular degeneration, rising awareness of personalized medicine, higher healthcare expenditure, and growing investment in ophthalmic research. Key trends anticipated for the forecast period include strategic collaborations between biotechnology firms, research institutes, and healthcare providers, deployment of artificial intelligence and machine learning in ophthalmology, integration of genomics with digital health technologies, rapid advancements in genetic and cellular therapies, and adoption of advanced technological solutions.

The growing prevalence of chronic vision disorders is expected to drive the expansion of the personalized ophthalmology therapies market. Chronic vision disorders are long-term eye conditions that progressively impair vision and often require continuous management. The rise in these disorders is closely linked to the increasing global incidence of diabetes, which can lead to complications such as diabetic retinopathy-a condition that gradually damages the retina over time. Personalized ophthalmology therapies are designed to address such chronic disorders by tailoring treatment plans based on an individual's genetic and molecular profile. This personalized approach enhances treatment effectiveness and helps slow disease progression. For example, in May 2024, the Centers for Disease Control and Prevention, a government health agency in the United States, projected that if effective interventions are not implemented, the number of diabetic retinopathy cases will increase by 72 percent, while cataract cases are expected to grow by 87 percent by the year 2050. These trends underscore the growing demand for individualized treatments in ophthalmology.

Leading companies in the personalized ophthalmology therapies market are advancing the development of single-dose intravitreal gene therapies to reduce the frequency of treatments and associated complications. These therapies involve a one-time injection into the vitreous cavity of the eye to deliver genetic material that targets the underlying cause of the disorder, providing long-lasting therapeutic effects. For instance, in July 2025, Sanofi, a pharmaceutical and healthcare company based in France, received fast track designation from the United States Food and Drug Administration for SAR446597, a single-dose intravitreal gene therapy aimed at treating geographic atrophy caused by age-related macular degeneration. This therapy delivers genetic material that encodes two antibody fragments which inhibit components of the classical and alternative complement pathways, specifically targeting C1s and factor Bb. By suppressing these pathways, the treatment aims to slow disease progression in the retina and reduce the need for repeated injections. The fast track designation is intended to accelerate the development and regulatory review process for therapies that address serious medical conditions with limited treatment options.

In June 2022, Novartis, a pharmaceutical company headquartered in Switzerland, acquired Kedalion Therapeutics for an undisclosed amount. This acquisition enables Novartis to expand its capabilities in precision ocular drug delivery technologies. Kedalion Therapeutics has developed innovative approaches to enhance the administration and effectiveness of eye treatments while improving patient comfort. The acquisition aligns with Novartis' strategic focus on delivering patient-centric, personalized solutions for a broad range of eye conditions and reinforces its position in the ophthalmology market.

Major players in the personalized ophthalmology therapies market are Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.

North America was the largest region in the personalized ophthalmology therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized ophthalmology therapies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized ophthalmology therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized ophthalmology therapies market includes revenues earned by entities by providing services such as molecular profiling, biomarker identification, patient data integration services, and disease risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Ophthalmology Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized ophthalmology therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized ophthalmology therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized ophthalmology therapies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Gene Therapy; Cell Therapy; Pharmacogenomics; Targeted Drug Delivery; Other Therapy Types
2) By Indication: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinitis Pigmentosa; Other Indications
3) By End User: Hospitals; Specialty Clinics; Research Institutes; Other End Users
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Gene Therapy; CRISPR Or Cas9-Based Gene Editing
2) By Cell Therapy: Stem Cell Therapy; Retinal Pigment Epithelial (RPE) Cell Therapy; Induced Pluripotent Stem Cell (iPSC) Therapy
3) By Pharmacogenomics: Drug Response Testing; Genetic Biomarker-Based Therapy; Personalized Drug Dosing
4) By Targeted Drug Delivery: Nanoparticle-Based Delivery; Liposomal Drug Delivery; Hydrogel-Based Delivery Systems
5) By Other Therapy Types: RNA-Based Therapy; Antisense Oligonucleotide Therapy; Peptide-Based Therapy
Companies Mentioned: Roche Holding AG; Novartis AG; Regeneron Pharmaceuticals Inc.; Alcon Inc.; Genentech Inc.; Bausch + Lomb Corporation; Johnson & Johnson Vision Care Inc.; Carl Zeiss Meditec AG; Santen Pharmaceutical Co. Ltd.; Ocular Therapeutix Inc.; EyePoint Pharmaceuticals Inc.; Senju Pharmaceutical Co. Ltd.; MeiraGTx Ltd.; Beacon Therapeutics; Clearside Biomedical Inc.; Adverum Biotechnologies Inc.; Ocugen Inc.; GenSight Biologics; Nanoscope Therapeutics Inc.; 4D Molecular Therapeutics Inc.; Coave Therapeutics.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38601

1. Executive Summary

2. Personalized Ophthalmology Therapies Market Characteristics

3. Personalized Ophthalmology Therapies Market Trends And Strategies

4. Personalized Ophthalmology Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Ophthalmology Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Ophthalmology Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Ophthalmology Therapies Market Growth Rate Analysis
5.4. Global Personalized Ophthalmology Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Ophthalmology Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Ophthalmology Therapies Total Addressable Market (TAM)

6. Personalized Ophthalmology Therapies Market Segmentation

6.1. Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Cell Therapy
Pharmacogenomics
Targeted Drug Delivery
Other Therapy Types
6.2. Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Age-Related Macular Degeneration
Diabetic Retinopathy
Glaucoma
Retinitis Pigmentosa
Other Indications
6.3. Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Institutes
Other End Users
6.4. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Vector-Based Gene Therapy
Non-Viral Gene Therapy
CRISPR Or Cas9-Based Gene Editing
6.5. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapy
Retinal Pigment Epithelial (RPE) Cell Therapy
Induced Pluripotent Stem Cell (iPSC) Therapy
6.6. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Response Testing
Genetic Biomarker-Based Therapy
Personalized Drug Dosing
6.7. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticle-Based Delivery
Liposomal Drug Delivery
Hydrogel-Based Delivery Systems
6.8. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RNA-Based Therapy
Antisense Oligonucleotide Therapy
Peptide-Based Therapy

7. Personalized Ophthalmology Therapies Market Regional And Country Analysis

7.1. Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Ophthalmology Therapies Market

8.1. Asia-Pacific Personalized Ophthalmology Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Ophthalmology Therapies Market

9.1. China Personalized Ophthalmology Therapies Market Overview
9.2. China Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Ophthalmology Therapies Market

10.1. India Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Ophthalmology Therapies Market

11.1. Japan Personalized Ophthalmology Therapies Market Overview
11.2. Japan Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Ophthalmology Therapies Market

12.1. Australia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Ophthalmology Therapies Market

13.1. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Ophthalmology Therapies Market

14.1. South Korea Personalized Ophthalmology Therapies Market Overview
14.2. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Ophthalmology Therapies Market

15.1. Western Europe Personalized Ophthalmology Therapies Market Overview
15.2. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Ophthalmology Therapies Market

16.1. UK Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Ophthalmology Therapies Market

17.1. Germany Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Ophthalmology Therapies Market

18.1. France Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Ophthalmology Therapies Market

19.1. Italy Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Ophthalmology Therapies Market

20.1. Spain Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Ophthalmology Therapies Market

21.1. Eastern Europe Personalized Ophthalmology Therapies Market Overview
21.2. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Ophthalmology Therapies Market

22.1. Russia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Ophthalmology Therapies Market

23.1. North America Personalized Ophthalmology Therapies Market Overview
23.2. North America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Ophthalmology Therapies Market

24.1. USA Personalized Ophthalmology Therapies Market Overview
24.2. USA Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Ophthalmology Therapies Market

25.1. Canada Personalized Ophthalmology Therapies Market Overview
25.2. Canada Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Ophthalmology Therapies Market

26.1. South America Personalized Ophthalmology Therapies Market Overview
26.2. South America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Ophthalmology Therapies Market

27.1. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Ophthalmology Therapies Market

28.1. Middle East Personalized Ophthalmology Therapies Market Overview
28.2. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Ophthalmology Therapies Market

29.1. Africa Personalized Ophthalmology Therapies Market Overview
29.2. Africa Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Ophthalmology Therapies Market Competitive Landscape And Company Profiles

30.1. Personalized Ophthalmology Therapies Market Competitive Landscape
30.2. Personalized Ophthalmology Therapies Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Ophthalmology Therapies Market Other Major And Innovative Companies

31.1. Bausch + Lomb Corporation
31.2. Johnson & Johnson Vision Care Inc.
31.3. Carl Zeiss Meditec AG
31.4. Santen Pharmaceutical Co. Ltd.
31.5. Ocular Therapeutix Inc.
31.6. EyePoint Pharmaceuticals Inc.
31.7. Senju Pharmaceutical Co. Ltd.
31.8. MeiraGTx Ltd.
31.9. Beacon Therapeutics
31.10. Clearside Biomedical Inc.
31.11. Adverum Biotechnologies Inc.
31.12. Ocugen Inc.
31.13. GenSight Biologics
31.14. Nanoscope Therapeutics Inc.
31.15. 4D Molecular Therapeutics Inc.

32. Global Personalized Ophthalmology Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Ophthalmology Therapies Market

34. Recent Developments In The Personalized Ophthalmology Therapies Market

35. Personalized Ophthalmology Therapies Market High Potential Countries, Segments and Strategies

35.1 Personalized Ophthalmology Therapies Market In 2029 - Countries Offering Most New Opportunities
35.2 Personalized Ophthalmology Therapies Market In 2029 - Segments Offering Most New Opportunities
35.3 Personalized Ophthalmology Therapies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer